Jonas Willmann, MD (@jonas_willmann) 's Twitter Profile
Jonas Willmann, MD

@jonas_willmann

Radiation Oncologist | Research scholar @MSKCancerCenter and @Unispital_USZ | interested in 🫁, reirradiation & oligometastatic disease

ID: 2408978660

linkhttps://scholar.google.com/citations?user=smUWeEgAAAAJ&hl=en calendar_today24-03-2014 13:00:12

271 Tweet

323 Takipçi

663 Takip Edilen

Melek Tugce Yilmaz MD (@mtugceyilmaz) 's Twitter Profile Photo

🚨 Just out in Red Journal! We analyzed our 191-patient H&N reirradiation cohort, with a specific focus on toxicity and CBOS 📊 Real-world SBRT data 🧑‍⚕️ Lessons on patient selection & risk mitigation redjournal.org/article/S0360-… IJROBP - The Red Journal Gozde Yazici Alper Kahvecioglu MD Ecem Yigit

🚨 Just out in Red Journal! 

We analyzed our 191-patient H&N reirradiation cohort, with a specific focus on toxicity and CBOS

📊 Real-world SBRT data
🧑‍⚕️ Lessons on patient selection & risk mitigation

redjournal.org/article/S0360-…

<a href="/IJROBP/">IJROBP - The Red Journal</a> <a href="/YaziciYazicig/">Gozde Yazici</a> <a href="/kahvecioglu_a/">Alper Kahvecioglu MD</a> <a href="/EcemYigitMD/">Ecem Yigit</a>
Felix Ehret (@felixehretmd) 's Twitter Profile Photo

The ESTRO is conducting a survey on reirradiation for brain tumors - please take a moment to fill it out and help us gather valuable insights that could inform future research! ASTRO SNO EANO surveymonkey.com/r/NK3G7D6

Katsuaki Maehara 🇯🇵 (@katsuakimaehara) 's Twitter Profile Photo

1/3 🫁 #TTF-1 is a new marker to identify patients best suited for #lung cancer KRAS inhibitors 🫁 🫁 #Sotorasib - #KRAS G12C mut 🫁 🌟 #Lung cancer patients with high #TTF-1 expression had improved survival outcomes after treatment with the #KRAS inhibitor #Sotrasib.

1/3

🫁 #TTF-1 is a new marker to identify patients best suited for #lung cancer KRAS inhibitors 🫁

🫁 #Sotorasib - #KRAS G12C mut 🫁

🌟 #Lung cancer patients with high #TTF-1 expression had improved survival outcomes after treatment with the #KRAS inhibitor #Sotrasib.
Drew Moghanaki (@drewmoghanaki) 's Twitter Profile Photo

New data from the randomized PEMBRO-RT study demonstrate when an ICI-mediated Abscopal effect is most likely to occur in patients with stage IV NSCLC. Ralph Weichselbaum Sean Pitroda, M.D. Amy L. Cummings, MD PhD doi.org/10.1038/s43018…

New data from the randomized PEMBRO-RT study demonstrate when an ICI-mediated Abscopal effect is most likely to occur in patients with stage IV NSCLC. <a href="/rweichselbaum/">Ralph Weichselbaum</a> <a href="/SeanPitroda/">Sean Pitroda, M.D.</a> <a href="/dramycummings/">Amy L. Cummings, MD PhD</a> doi.org/10.1038/s43018…